ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 44 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -99.9% | 2,000 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -83.3% | 2,000 | -50.0% | 0.00% | – |
Q4 2021 | $6,000 | -25.0% | 4,000 | +20.4% | 0.00% | – |
Q3 2021 | $8,000 | -20.0% | 3,321 | +56.2% | 0.00% | – |
Q2 2021 | $10,000 | -41.2% | 2,126 | -6.5% | 0.00% | – |
Q1 2021 | $17,000 | +70.0% | 2,274 | +2.4% | 0.00% | – |
Q4 2020 | $10,000 | +25.0% | 2,221 | +4.7% | 0.00% | – |
Q3 2020 | $8,000 | +700.0% | 2,121 | +1652.9% | 0.00% | – |
Q2 2020 | $1,000 | -93.8% | 121 | -94.2% | 0.00% | – |
Q1 2020 | $16,000 | -50.0% | 2,077 | -8.1% | 0.00% | – |
Q4 2019 | $32,000 | -82.5% | 2,261 | -85.3% | 0.00% | – |
Q3 2019 | $183,000 | +110.3% | 15,427 | +150.2% | 0.00% | – |
Q2 2019 | $87,000 | +4250.0% | 6,167 | +4954.9% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 122 | +22.0% | 0.00% | – |
Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |